Charles Faith L. purchased $34K of ABEO
Charles Faith L. purchased 15,000 shares of ABEONA THERAPEUTICS INC. (ABEO) at $2.29 on 2026-11-13.
How this was made
The 30-second read
Why it matters
The director's modest purchase adds a small amount of buying pressure but is unlikely to influence ABEO's stock price significantly.
Market read
A routine insider purchase with limited relevance for traders.
What to watch
Potential upcoming clinical trial updates that prompted the director's buy.
Background
SEC Form 4 filing discloses insider transactions. Abeona Therapeutics (ABEO) is a NASDAQ-listed biotech company.
Ticker impact
Director Charles Faith L. bought 15,000 ABEO shares for $34,348.50 on 2026-11-13, raising his holding to 191,407 shares.
minor upward pressure as insider buying signals confidence, but size is too small to move price materially
The transaction is a modest $34K purchase by a director, indicating personal confidence but unlikely to affect broader market sentiment.
Market effects
None; Abeona operates in biotech but the trade is too small to affect sector sentiment.
None; limited to US biotech investors.
None
Counterpoint
The purchase could be a signal of upcoming positive news not yet public.
Key entities
- CompanyAbeona Therapeutics Inc.
NASDAQ-listed biotech firm developing gene therapies.
- IndividualCharles Faith L.
Director of Abeona Therapeutics.


